ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Jpmorgan Multi-asset Growth & Income Plc

Jpmorgan Multi-asset Growth & Income Plc (MATE)

103.00
0.00
(0.00%)
Closed 18 December 3:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
103.00
Bid
0.00
Offer
0.00
Volume
0.00
0.00 Day's Range 0.00
95.00 52 Week Range 103.00
Previous Close
103.00
Open
-
Last Trade
(O)
Last Trade Time
Average Volume (3m)
0.00
Financial Volume
-
VWAP
-

MATE Latest News

London Stock Exchange Notice Cancellation - JPMORGAN MULTI-ASSET GRWTH & INCOME

London Stock Exchange Notice 27 March 2024   NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON THE LONDON STOCK EXCHANGE   27/03/2024 - 08:00   At the request of the company the following...

JPMorgan Multi-Asset Grwth & Income Result 2nd General Meeting & Scheme Entitlements

JPMorgan Multi-Asset Grwth & Income 26 March 2024   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM THE UNITED STATES OF AMERICA...

JPMorgan Multi-Asset Grwth & Income Net Asset Value(s)

JPMorgan Multi-Asset Grwth & Income 26 March 2024   JPMORGAN MULTI-ASSET GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300C0UCY8X2QXW762 THE COMPANY ANNOUNCES THE...

JPMorgan Multi-Asset Grwth & Income Gearing Announcement

JPMorgan Multi-Asset Grwth & Income 25 March 2024   JPMORGAN MULTI-ASSET GROWTH & INCOME PLC (the 'Company')   Inclusive of open exposure in Bond and Equity Index Futures Legal...

JPMorgan Multi-Asset Grwth & Income Net Asset Value(s)

JPMorgan Multi-Asset Grwth & Income 25 March 2024   JPMORGAN MULTI-ASSET GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300C0UCY8X2QXW762 THE COMPANY ANNOUNCES THE...

London Stock Exchange Notice Suspension - JPM Multi-Asset Growth & Income PLC

London Stock Exchange Notice 25 March 2024   NOTICE   25/03/2024 7:30am   TEMPORARY SUSPENSION OF TRADING ON MAIN MARKET - PREMIUM SEGMENT   JPMORGAN MULTI-ASSET GROWTH & INCOME PLC   At...

JPMorgan Multi-Asset Grwth & Income Net Asset Value(s)

JPMorgan Multi-Asset Grwth & Income 22 March 2024   JPMORGAN MULTI-ASSET GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300C0UCY8X2QXW762 THE COMPANY ANNOUNCES THE...

JPMorgan Multi-Asset Grwth & Income Net Asset Value(s)

JPMorgan Multi-Asset Grwth & Income 21 March 2024   JPMORGAN MULTI-ASSET GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300C0UCY8X2QXW762 THE COMPANY ANNOUNCES THE...

JPMorgan Multi-Asset Grwth & Income Net Asset Value(s)

JPMorgan Multi-Asset Grwth & Income 20 March 2024   JPMORGAN MULTI-ASSET GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300C0UCY8X2QXW762 THE COMPANY ANNOUNCES THE...

JPMorgan Multi-Asset Grwth & Income Net Asset Value(s)

JPMorgan Multi-Asset Grwth & Income 19 March 2024   JPMORGAN MULTI-ASSET GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300C0UCY8X2QXW762 THE COMPANY ANNOUNCES THE...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10010310310300DE
40010310310300DE
120010310310300DE
260010310310300DE
5277.2916666666796103951924898.27700594DE
156-3.5-3.28638497653106.5109864085696.36303492DE
26000103109657344695.38853077DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TM1Technology Minerals Plc
0.265p
(140.91%)
635.73M
HUMHummingbird Resources Plc
2.30p
(39.39%)
8.51M
QEDQuadrise Plc
6.00p
(29.03%)
28.48M
LPALpa Group Plc
72.00p
(26.32%)
63.26k
DARDar Global Plc
US$ 6.00
(22.45%)
16.75k
APIAbrdn Property Income Trust Limited
9.51p
(-84.36%)
13.57M
KDNCCadence Minerals Plc
1.65p
(-40.00%)
17.87M
BLUBlue Star Capital Plc
0.015p
(-25.00%)
18.2M
SYMESupply@me Capital Plc
0.0034p
(-22.73%)
1.43B
SCGLSealand Capital Galaxy Limited
1.40p
(-22.22%)
6.15M
NTVONativo Resources Plc
0.0021p
(-12.50%)
4.78B
SYMESupply@me Capital Plc
0.0034p
(-22.73%)
1.43B
TRPTower Resources Plc
0.031p
(8.77%)
637.54M
TM1Technology Minerals Plc
0.265p
(140.91%)
635.73M
ORCPOracle Power Plc
0.026p
(-3.70%)
340.06M

Discussion

View Full Feed
JMoneyHoops JMoneyHoops 5 minutes ago
Verified profile! https://x.com/jmoney_hoops/status/1869205515588501520?s=46&t=EuLw-SVIgNfV5yGP5vc4tQ
EATR
dstock07734 dstock07734 5 minutes ago
Yes
NWBO
KILLAZILLA KILLAZILLA 6 minutes ago
DILUTION IS THE MAIN EYESORE....

WITHOUT SUBSTANTIAL REVENUE IT'S A POS DILUTION SCAM......
TLRY
gitreal gitreal 6 minutes ago
...where would our country be without folks daring to dream?

Pretty sad that you can't tell the difference between a grifting penny stock CEO and a legit startup entrepreneur. Or, even worse, you do know the difference and you are pretending, just to help promote the scam. I think i
NBRI
flipper44 flipper44 7 minutes ago
Those people know we can still see them, right?
NWBO
awesomed007 awesomed007 7 minutes ago
If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.
RDAR
awesomed007 awesomed007 7 minutes ago
If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.
RDAR
Eatatjoes Eatatjoes 7 minutes ago
Paul Malec of Deer Park, NY
QOIL
fuagf fuagf 7 minutes ago
Yeps, yeps and yeps. Good ones.
NoMoDo NoMoDo 7 minutes ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175527881 Meeting announced for TODAY

Better yet. Read this closely:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175530469
Ybyra agreed to purchase a company in France. Giving Dividends.
HMBL
manibiotech manibiotech 8 minutes ago
Well if you read the link you posted yourself , they are tracking in almost every other country on the planet . Please see the table . They are giving projected global scope of what is going on
I have no problem with you posting that link every hour of that pleases you 
NWBO
1vman 1vman 8 minutes ago
*****🚽UBQU🚽 Kevin Lamb is the typical OTC CEO , pocketing money while share holders lose amost all their investment

So much for forbes and da T0P 10 Health innovators wow!

🤔HUZZAH ENOUGH SAID !!!🤔
UBQU
janice shell janice shell 9 minutes ago
First of all, Syria is not a big oil producer. So it's a stupid idea. Trump has put it forward because he thinks everything should be his.

And because he's a moron.

https://investorshub.advfn.com/uimage/uploads/2024/12/17/oage%5BJPEG_image.jpeg

I must so
HappyAlways HappyAlways 10 minutes ago
I am, as a Fannie shareholder, against any government action to dilute Fannie shareholders' interest. (1) The PSPA loan is no longer valid, given the NWS payments are way over the original 10% interest payments by $310B. (2) Any attempt to exercise the free warrant will be met with lawsuits, given t
FNMA
TheDane TheDane 10 minutes ago
Not only did it hold but it’s on the way back up.
SMCI
OnTrack444 OnTrack444 10 minutes ago
Might see a dime after the RS!  

If you think a 30B OS OTC stock is going to run from .0011 to .10 you're smoking something pretty whacky!!  Find a low OS stock with catalysts in place and it's entirely possible but not this one my friend!!!  GLTY
HMBL
manibiotech manibiotech 11 minutes ago
Interesting for sure but not conclusive which he repeat every day 

But there are other things mentioned in that paragraph besides "Neuroscience" ( not Neuro-oncology). And there are other categories of vaccines in development even in neuroscience 


NWBO
FACT-MASTER FACT-MASTER 12 minutes ago
Pivotal Study Design.

Through a meeting with the FDA, the Company obtained feedback on the potential registrational pathway following the Phase 1 ALLOHA trial. Based on this feedback, the Company believes that for a registrational trial: (1) the following proposed patient population i
CDMO
arizona1 arizona1 13 minutes ago
Never trumpers are hilarious and brilliant too.
jimr1717 jimr1717 14 minutes ago
“ which now includes 17 issued U.S. patents and 84 pending”

It has taken them from $90,000 to $2 bucks in share price to get 17 of 101 patents.

There will be people that might need a million dollar share price to brake even by then.

This Fake it sham is
SINT
NoMoDo NoMoDo 15 minutes ago
If we don't see a dime, I will be shocked.
HMBL
Slyhunter Slyhunter 15 minutes ago
I did Uber, when it was worth doing. Made, sometimes $300 a day at the b3e3ginning when they first started in my county, It was disastrous to not get out of the car and inspect the backseat to insure it was clean between fares, especially when driving dr8u8nks home at night. I don't see how Tesla is
TSLA
nfrequent nfrequent 15 minutes ago
Get ready. Phase One complete!!!
https://archive.fast-edgar.com/20241217/AP2Z522CZZ2R52V222JG2WY2CDQEZZ226L62/
RNVA
XMaster2023 XMaster2023 15 minutes ago
Well now kinda sensitive. We can only talk about others tracking the approval one time because it doesn’t meet your short agenda? Funny how an American Society are tracking approval in the UK. They understand the approval will have a big impact on the gene therapy world. Your tacid comments will
NWBO